Clinical and Prognostic Value of Immunogenetic Characteristics in Anti-LGI1 Encephalitis. Issue 3 (May 2021)
- Record Type:
- Journal Article
- Title:
- Clinical and Prognostic Value of Immunogenetic Characteristics in Anti-LGI1 Encephalitis. Issue 3 (May 2021)
- Main Title:
- Clinical and Prognostic Value of Immunogenetic Characteristics in Anti-LGI1 Encephalitis
- Authors:
- Muñiz-Castrillo, Sergio
Haesebaert, Julie
Thomas, Laure
Vogrig, Alberto
Pinto, Anne-Laurie
Picard, Géraldine
Blanc, Charlotte
Do, Le-Duy
Joubert, Bastien
Berzero, Giulia
Psimaras, Dimitri
Alentorn, Agusti
Rogemond, Véronique
Dubois, Valérie
Ambati, Aditya
Tamouza, Ryad
Mignot, Emmanuel
Honnorat, Jérôme - Abstract:
- Abstract : Objective: Antibodies against leucine-rich glioma-inactivated 1 (LGI1-Abs) characterize a limbic encephalitis (LE) strongly associated with HLA-DRB1*07:01, although some patients lack LGI1-Abs in CSF or do not carry this allele. Whether they represent a different subtype of disease or have different prognoses is unclear. Methods: Retrospective analysis of clinical features, IgG isotypes, and outcome according to LGI1-Ab CSF positivity and DRB1*07:01 in a cohort of anti-LGI1 LE patients. Results: Patients with LGI1-Abs detected in both CSF and serum (105/134, 78%) were compared with those who were CSF negative (29/134, 22%). Both groups had similar clinical features and serum levels, but CSF-positive patients had shorter diagnostic delay, more frequently hyponatremia, inflammatory CSF, and abnormal MRI ( p < 0.05). Human leukocyte antigen (HLA) genotyping was performed in 72/134 (54%) patients and 63/72 (88%) carried DRB1*07:01. Noncarriers (9/72, 12%) were younger, more commonly women, and had less frequently psychiatric and frontal symptoms ( p < 0.05). No difference in IgG isotypes according to CSF positivity or HLA was found ( p > 0.05). HLA and IgG isotypes were not associated with poor outcome (mRS >2 at last follow-up) in univariate analyses; CSF positivity was only identified as a poor outcome predictor in the multivariate analysis including the complete follow-up, whereas age and female sex also remained when just the first year was considered.Abstract : Objective: Antibodies against leucine-rich glioma-inactivated 1 (LGI1-Abs) characterize a limbic encephalitis (LE) strongly associated with HLA-DRB1*07:01, although some patients lack LGI1-Abs in CSF or do not carry this allele. Whether they represent a different subtype of disease or have different prognoses is unclear. Methods: Retrospective analysis of clinical features, IgG isotypes, and outcome according to LGI1-Ab CSF positivity and DRB1*07:01 in a cohort of anti-LGI1 LE patients. Results: Patients with LGI1-Abs detected in both CSF and serum (105/134, 78%) were compared with those who were CSF negative (29/134, 22%). Both groups had similar clinical features and serum levels, but CSF-positive patients had shorter diagnostic delay, more frequently hyponatremia, inflammatory CSF, and abnormal MRI ( p < 0.05). Human leukocyte antigen (HLA) genotyping was performed in 72/134 (54%) patients and 63/72 (88%) carried DRB1*07:01. Noncarriers (9/72, 12%) were younger, more commonly women, and had less frequently psychiatric and frontal symptoms ( p < 0.05). No difference in IgG isotypes according to CSF positivity or HLA was found ( p > 0.05). HLA and IgG isotypes were not associated with poor outcome (mRS >2 at last follow-up) in univariate analyses; CSF positivity was only identified as a poor outcome predictor in the multivariate analysis including the complete follow-up, whereas age and female sex also remained when just the first year was considered. Conclusions: LE without CSF LGI1-Abs is clinically indistinguishable and likely reflects just a lesser LGI1-Ab production. HLA association is sex and age biased and presents clinical particularities, suggesting subtle differences in the immune response. Long-term outcome depends mostly on demographic characteristics and the intensity of the intrathecal synthesis. … (more)
- Is Part Of:
- Neurology. Volume 8:Issue 3(2021)
- Journal:
- Neurology
- Issue:
- Volume 8:Issue 3(2021)
- Issue Display:
- Volume 8, Issue 3 (2021)
- Year:
- 2021
- Volume:
- 8
- Issue:
- 3
- Issue Sort Value:
- 2021-0008-0003-0000
- Page Start:
- Page End:
- Publication Date:
- 2021-05
- Subjects:
- Neuroimmunology -- Periodicals
Neurology -- Periodicals
616.8 - Journal URLs:
- http://nn.neurology.org/ ↗
http://journals.lww.com/pages/default.aspx ↗ - DOI:
- 10.1212/NXI.0000000000000974 ↗
- Languages:
- English
- ISSNs:
- 2332-7812
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6081.502260
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 18968.xml